Vaccinex, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Vaccinex, Inc. (VCNX) had Stockholders' Equity Attributable to Noncontrolling Interest of $21.96 million as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2022-03-31
- 2021-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $21.96M.
- 2020-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $23.96M.
- 2020-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $23.96M.
- 2020-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $23.96M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2021-03-31 | $21.96M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $23.96M 10-K · filed 2022-03-31 |
| 2020-09-30 | $23.96M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $23.96M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $23.96M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $23.96M 10-K · filed 2021-03-31 |
| 2019-09-30 | $23.96M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $23.96M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $23.96M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $23.96M 10-K · filed 2020-03-09 |
| 2018-09-30 | $23.96M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $23.96M 10-Q · filed 2018-08-14 |
| 2017-12-31 | $11.96M 10-K · filed 2019-03-13 |